 |
Formulary: Over-the-Counter Medications
|
1/29/2018 |
ConnectorCare or QHP |
|
Policy: Medication Exception Process
|
11/19/2012 |
ConnectorCare or QHP |
|
MassHealth PBHMI Prior Authorization Form
|
5/3/2019 |
MassHealth |
|
Age & Quantity Limitation Program Policy (Policy MA9.050), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Non-Formulary Exceptions (Policy MA9.051), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Cystic Fibrosis Agents (Policy MA9.100), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Hereditary Angioedema (Policy MA9.101), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Topical Immunomodulators (Policy MA9.103), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Sublingual Immunotherapy (SLIT) Medications (Policy MA9.104), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Esbriet (Policy MA9.105), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Nplate (Policy MA9.106), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Promacta (Policy MA9.107), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Krystexxa (Pegloticase) (Policy MA9.108), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Immune Globulin (Policy MA9.110), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Daliresp (Policy MA9.111), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Acthar H.P. Gel (Policy MA9.112), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Benlysta (Belimumab) (Policy MA9.115), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Entyvio (Policy MA9.120), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Infliximab Products (Policy MA9.123), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Methotrexate (Policy MA9.125), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Complement Inhibitors (Policy MA9.134), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Myalept (Policy MA9.307), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Natpara (Policy MA9.309), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
Trientine (Syprine) (Policy MA9.310), Effective 01/01/2021
|
12/22/2020 |
MassHealth |
|
FAQs: Pediatric Behavioral Health Medication Initiative (PBHMI)
|
1/29/2018 |
MassHealth |
|
Formulary: Over-the-Counter Medications
|
1/29/2018 |
MassHealth |
|
Non-Preferred Drug Exception Request
|
7/25/2018 |
MassHealth |
|
List: MassHealth ACPP/MCO Uniform Preferred Drug List
|
1/9/2019 |
MassHealth |
|
Policy: Medication Exception Process
|
11/19/2012 |
MassHealth |
|
SCO Policy and Prior Authorization Program Changes, May 2022
|
7/28/2021 |
SCO |
|
Formulary: Over-the-Counter Medications
|
12/15/2015 |
SCO |
